Advertisement
Screener

ACADIA PHARMACEUTICALS INC. (ACAD) Preferred Stock, Shares Authorized

2.8 / 5 stars · 68/120 Roast Me

ACADIA PHARMACEUTICALS INC. Preferred Stock, Shares Authorized

ACADIA PHARMACEUTICALS INC. (ACAD) had Preferred Stock, Shares Authorized of 5.00 million shares as of 2026-06-30, per its 10-Q filed 2026-08-05.

Financial Statements › Balance Sheet › Equity › Stockholders' Equity, Number of Shares, Par Value and Other Disclosure › Preferred Stock, Number of Shares, Par Value and Other Disclosure

us-gaap:PreferredStockSharesAuthorized · last filed 2026-08-05

  • 2026-06-30: Preferred Stock, Shares Authorized 5.00M shares.
  • 2026-03-31: Preferred Stock, Shares Authorized 5.00M shares.
  • 2025-12-31: Preferred Stock, Shares Authorized 5.00M shares.
  • 2025-09-30: Preferred Stock, Shares Authorized 5.00M shares.
Period endPreferred Stock, Shares Authorized
2026-06-305.00M shares
10-Q · filed 2026-08-05
2026-03-315.00M shares
10-Q · filed 2026-05-07
2025-12-315.00M shares
10-Q · filed 2026-08-05
2025-09-305.00M shares
10-Q · filed 2025-11-06
2025-06-305.00M shares
10-Q · filed 2025-08-07
2025-03-315.00M shares
10-Q · filed 2025-05-08
2024-12-315.00M shares
10-K · filed 2026-02-26
2024-09-305.00M shares
10-Q · filed 2024-11-07
2024-06-305.00M shares
10-Q · filed 2024-08-07
2024-03-315.00M shares
10-Q · filed 2024-05-09
2023-12-315.00M shares
10-K · filed 2025-02-27
2023-09-305.00M shares
10-Q · filed 2023-11-03
2023-06-305.00M shares
10-Q · filed 2023-08-03
2023-03-315.00M shares
10-Q · filed 2023-05-08
2022-12-315.00M shares
10-K · filed 2024-02-28
2022-09-305.00M shares
10-Q · filed 2022-11-03
2022-06-305.00M shares
10-Q · filed 2022-08-09
2022-03-315.00M shares
10-Q · filed 2022-05-05
2021-12-315.00M shares
10-K · filed 2023-02-28
2021-09-305.00M shares
10-Q · filed 2021-11-09
2021-06-305.00M shares
10-Q · filed 2021-08-05
2021-03-315.00M shares
10-Q · filed 2021-05-06
2020-12-315.00M shares
10-K · filed 2022-03-01
2020-09-305.00M shares
10-Q · filed 2020-11-04
2020-06-305.00M shares
10-Q · filed 2020-08-06
2020-03-315.00M shares
10-Q · filed 2020-05-08
2019-12-315.00M shares
10-K · filed 2021-02-25
2019-09-305.00M shares
10-Q · filed 2019-10-31
2019-06-305.00M shares
10-Q · filed 2019-08-01
2019-03-315.00M shares
10-Q · filed 2019-05-02
2018-12-315.00M shares
10-K · filed 2020-02-27
2018-09-305.00M shares
10-Q · filed 2018-11-06
2018-06-305.00M shares
10-Q · filed 2018-08-08
2018-03-315.00M shares
10-Q · filed 2018-05-04
2017-12-315.00M shares
10-K · filed 2019-02-27
2017-09-305.00M shares
10-Q · filed 2017-11-07
2017-06-305.00M shares
10-Q · filed 2017-08-08
2017-03-315.00M shares
10-Q · filed 2017-05-09
2016-12-315.00M shares
10-K · filed 2018-02-27
2016-09-305.00M shares
10-Q · filed 2016-11-07
2016-06-305.00M shares
10-Q · filed 2016-08-04
2016-03-315.00M shares
10-Q · filed 2016-05-05
2015-12-315.00M shares
10-K · filed 2017-02-28
2015-09-305.00M shares
10-Q · filed 2015-11-05
2015-06-305.00M shares
10-Q · filed 2015-08-06
2015-03-315.00M shares
10-Q · filed 2015-05-07
2014-12-315.00M shares
10-K · filed 2016-02-29
2014-09-305.00M shares
10-Q · filed 2014-11-10
2014-06-305.00M shares
10-Q · filed 2014-08-05
2014-03-315.00M shares
10-Q · filed 2014-05-06
2013-12-315.00M shares
10-K · filed 2015-02-26
2013-09-305.00M shares
10-Q · filed 2013-11-06
2013-06-305.00M shares
10-Q · filed 2013-08-06
2013-03-315.00M shares
10-Q · filed 2013-05-07
2012-12-315.00M shares
10-K · filed 2014-02-27
2012-09-305.00M shares
10-Q · filed 2012-11-05
2012-06-305.00M shares
10-Q · filed 2012-08-08
2012-03-315.00M shares
10-Q · filed 2012-05-08
2011-12-315.00M shares
10-K · filed 2013-03-12
2011-09-305.00M shares
10-Q · filed 2011-11-09
2011-06-305.00M shares
10-Q · filed 2011-08-10
2010-12-315.00M shares
10-K · filed 2012-03-06

Similar stocks

Stock NameCountryMarket CapPE Ratio
AbCellera Biologics Inc. (ABCL)$3.879B-14.59
Xenon Pharmaceuticals Inc. (XENE)$3.684B-14.27
Organon & Co. (OGN)United States$3.603B17.03
IDEAYA Biosciences, Inc. (IDYA)United States$3.540B-20.52
Tango Therapeutics, Inc. (TNGX)United States$4.154B-42.53
Indivior Pharmaceuticals, Inc. (INDV)$4.250B14.09
Amylyx Pharmaceuticals, Inc. (AMLX)United States$3.361B-13.15
Viking Therapeutics, Inc. (VKTX)United States$4.287B-8.51
Enliven Therapeutics, Inc. (ELVN)United States$3.307B-35.07
Arcutis Biotherapeutics, Inc. (ARQT)United States$3.303B115.47